Kytogenics Pharmaceuticals Ltd.

Nova Scotia – Dartmouth – Dartmouth

Corporation

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Corporation

active

Kytogenics Pharmaceuticals, Inc. is a drug delivery and medical products company moving forward to develop and market a series of clinically significant therapies and products based on its N,O-carboxymethylchitosan (NOCC) chitosan derived technology and its sulphated derivative s-NOCC. Through the FDA 510K process Kytogenics has successfully cleared one product for marketing in its wound care/derma line, its NOCC Hydrophilic Wound Dressing, and the Company is developing additional diverse and innovative products lines based on its NOCC and s-NOCC Technology platforms.
Country of Ownership: Canada
Year Established: 1978
Exporting: No
Primary Industry (NAICS): 325190 - Other Basic Organic Chemical Manufacturing
Alternate Industries (NAICS): 325410 - Pharmaceutical and Medicine Manufacturing
Primary Business Activity: Manufacturer / Processor / Producer
Number of Employees: 7

Services:
Biotechnology

Products:
N,o-carboxmethylcitosan (nocc), Organic chemicals, Biochemical products

No associations

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian companies and directors. Rate them and share your experience with other people.

Rating

Kytogenics Pharmaceuticals Ltd. does not yet have a rating. At this time, there are no reviews or comments for this company.

If you have personal experience with Kytogenics Pharmaceuticals Ltd., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kytogenics Pharmaceuticals Ltd. will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-COD-O-14124

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.